Alchemia has struck a deal with AstraZeneca to search for disease-treating small molecules, which could be worth around $240 million.

Luci Ellis, head of the RBA's financial stability dept, says the shift to low inflation meant a one-off housing price jump but slower rises in the future.

Aurizon chief Lance Hockridge says the federal government should not invest in new rail infrastructure for transporting passengers.

In an ominous sign for the resources industry, Newcrest Mining has reacted to the gold price slump by reviewing higher-cost mines and cutting 150 jobs.

The Reject Shop is tapping its shareholders to help fund its aggressive store roll out across the country.